Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalfurafine for cholestatic pruritus in Chinese patients with chronic liver disease
ChiCTR2500101412Phase 4Not yet recruiting
- Sponsor
- Tianjin Central Hospital of Obstetrics and Gynecology
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nalfurafine in cholestatic pruritus, sponsored by Tianjin Central Hospital of Obstetrics and Gynecology. Primary endpoint: Change from baseline in Visual Analog Scale score at Week 12. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
nalfurafine
03
Conditions
cholestatic pruritus
Beyond the preview
Go deeper on ChiCTR2500101412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101412.